- Supporting Ebola Response: Rapid Diagnostics and Global Expertise
- ADLM 2026
- Protecting Food. Protecting People.
- Annual Report: Achievements Building a Healthier Future
- AMR is Rising — Stewardship Demands Global Leadership
News
bioMérieux's Q2 2026 sales totaled €981 million, with solid organic growth at +5%, reaching +7% excluding BIOFIRE® respiratory panels. The sales of the GO•28 growth drivers increased by 8.5% organically in Q2 26.
Swipe for more stories
-
bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026
bioMérieux hosted a press panel and accepted seven 2026 IMV ServiceTrak™ Clinical Laboratory Awards. These awards highlight bioMérieux’s continued commitment to delivering industry-leading diagnostic solutions and exceptional customer support to clinical laboratories. -
Tracking the Cyclospora cayetanensis Outbreak in the United States
bioMérieux's unique portfolio of clinical diagnostic and wastewater surveillance solutions can support community health and medical professionals in responding to the current outbreak.
-
bioMérieux to Showcase Company’s Latest in Diagnostic Innovations at ADLM 2026
bioMérieux announced it will showcase its latest diagnostic solutions and innovations at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Conference & Clinical Lab Expo.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19